Team
The VRI includes 150 researchers working on more than 40 international projects.
Mathieu Surenaud
Mathieu Surénaud, PhD in Life and Health Sciences, specialized in cellular and molecular biology (Université Paris-Est Créteil, 2019) is head of the Proteomic Division at the VRI. He brings over twenty years of experience in vaccine research. His focus is the definition of epitope mapping of pathogens, a critical step for the design of VRI’s vaccines. His team is in charge of the development of cellular and biomarkers assays using cutting-edge technologies (Luminex, Simoa and MSD technologies) used in the evaluation of VRI’s vaccine clinical trials.